Viewing Study NCT00305734


Ignite Creation Date: 2025-12-25 @ 2:20 AM
Ignite Modification Date: 2025-12-26 @ 12:52 AM
Study NCT ID: NCT00305734
Status: COMPLETED
Last Update Posted: 2013-01-25
First Post: 2006-03-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module